EMERYVILLE, Calif.--(BUSINESS WIRE)--BioTime, Inc. (OTCBB: BTIM) today announced financial results for the second quarter ended June 30, 2007. Revenues for the three months ended June 30, 2007 consist primarily of royalties on sales of Hextend® made by Hospira during the period beginning January 1, 2007 and ending March 31, 2007. Royalty revenues recognized for that three-month period were $163,676, a 64% increase from the $99,957 of royalty revenue during the same period last year, reflecting an increase in sales to hospitals and to the United States Armed Forces. BioTime recognizes royalty revenues in the quarter in which sales reports are received, rather than the quarter in which the sales took place.
